Biomarker identification in serum samples from patients with recurrent cervical cancer treated with ADXS11-001 immunotherapy

Lignende værker

• Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment
  af: Wallecha, Anu, et al.
  Udgivet: (2013)
• Lm-LLO immunotherapies targeting multiple antigens and their impact on different mechanisms in the tumor microenvironment
  af: Wallecha, Anu, et al.
  Udgivet: (2014)
• ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer
  af: Petit, Robert G, et al.
  Udgivet: (2014)
• High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
  af: Ghamande, Sharad, et al.
  Udgivet: (2015)
• ADXS11-001 immunotherapy targeting HPV-E7: updated survival and safety data from a phase 2 study in Indian women with recurrent/refractory cervical cancer
  af: Petit, Robert G, et al.
  Udgivet: (2013)